Annexon Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Annexon Biosciences (ANNX) PT Raised to $14 at Wells Fargo
June 5, 2024 5:54 AM EDTWells Fargo analyst Derek Archila raised the price target on Annexon Biosciences (NASDAQ: ANNX) to $14.00 (from $10.00) while maintaining a Overweight rating.
The analyst comments "ANX005 only had to win on one dose. Let's be clear: the study was powered... More
